Alembic Pharmaceuticals Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 10, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Market Capitalization	138,705	182,755	193,575	97,564	145,771	189,674
Market Cap Growth	-13.75%	-5.59%	98.41%	-33.07%	-23.15%	88.33%
Enterprise Value	152,129	192,124	200,785	104,548	151,109	193,139
Last Close Price	705.65	919.53	963.11	480.12	706.45	905.93
PE Ratio	22.01	31.33	31.43	28.53	27.98	16.54
Forward PE	17.18	25.37	28.71	19.15	19.76	18.14
PS Ratio	1.91	2.74	3.11	1.73	2.75	3.52
PB Ratio	2.61	3.52	4.02	2.23	2.78	3.74
P/TBV Ratio	2.72	3.52	4.02	2.23	2.87	4.00
P/FCF Ratio	-	-	40.69	34.78	115.04	23.60
P/OCF Ratio	-	207.75	24.10	13.48	26.39	12.96
PEG Ratio	0.70	1.13	1.09	1.89	-	1.24
EV/Sales Ratio	2.09	2.88	3.22	1.85	2.85	3.58
EV/EBITDA Ratio	13.28	19.42	21.97	15.02	17.60	13.17
EV/EBIT Ratio	17.65	26.33	30.39	23.88	25.72	14.89
EV/FCF Ratio	-	-	42.21	37.27	119.26	24.03
Debt / Equity Ratio	0.28	0.24	0.11	0.17	0.14	0.12
Debt / EBITDA Ratio	1.30	1.25	0.55	1.01	0.82	0.39
Debt / FCF Ratio	-	-	1.08	2.57	5.66	0.73
Net Debt / Equity Ratio	0.25	0.23	0.08	0.15	0.13	0.06
Net Debt / EBITDA Ratio	1.19	1.19	0.43	0.93	0.76	0.20
Net Debt / FCF Ratio	-	-2.47	0.83	2.31	5.18	0.37
Asset Turnover	-	0.94	0.99	0.85	0.77	0.85
Inventory Turnover	-	0.96	1.15	1.15	0.97	1.00
Quick Ratio	-	0.62	0.82	0.74	0.52	0.51
Current Ratio	-	1.70	2.12	1.78	1.67	2.07
Return on Equity (ROE)	-	11.63%	13.40%	7.12%	10.11%	27.77%
Return on Assets (ROA)	-	6.42%	6.54%	4.11%	5.31%	12.77%
Return on Invested Capital (ROIC)	10.58%	10.38%	12.59%	7.74%	8.69%	20.59%
Return on Capital Employed (ROCE)	-	13.60%	13.20%	9.60%	10.90%	23.90%
Earnings Yield	4.53%	3.19%	3.18%	3.50%	3.57%	6.04%
FCF Yield	-	-2.60%	2.46%	2.88%	0.87%	4.24%
Dividend Yield	1.55%	1.20%	1.14%	1.67%	1.42%	1.54%
Payout Ratio	-	37.06%	25.54%	57.48%	52.83%	-
Buyback Yield / Dilution	0.41%	-	-	-	-1.46%	-2.77%
Total Shareholder Return	1.96%	1.20%	1.14%	1.67%	-0.04%	-1.23%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.